Biological deposits for patenting purposes under the Budapest Treaty
Tim Fitzgerald
+ Author Affiliations
- Author Affiliations
IP Gateway
Suite 9a, Springwood Chambers
3360 Pacific Highway
Springwood
Brisbane, Qld 4127, Australia
Tel: +61 7 3808 3566
Email: tfitzgerald@ipgateway.com.au
Microbiology Australia 40(3) 114-116 https://doi.org/10.1071/MA19031
Published: 12 September 2019
Abstract
A patent confers a limited-term right to exclude other parties from using an invention, in exchange for a comprehensive description of the invention. The granted claims of a patent define the scope of the right that is conferred.
References
[1] Paris Convention for the Protection of Industrial Property, 20 March 1883, 828 UNTS 305 (Stockholm revision entered into force 26 March 1970).[2] Patent Cooperation Treaty, 19 June 1970, 1160 UNTS 231.
[3] Agreement on Trade-Related Aspects of Intellectual Property Rights, 15 April 1994, Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, 1869 UNTS 299.
[4] Sigareva, M.A. and O’Donnell, R.W. (2017) Global Strategies for Protecting Inventions in the Biotechnology Sector. New Jersey Lawyer. August, pp. 60–64.
[5] Fitzgerald, T.L. et al. (2016) Developments in the patentability of biotechnology in Australia and the United States – Part 1. Australian Intellectual Property Law Bulletin. 29, 23–26.
[6] Fitzgerald, T.L. et al. (2017) Developments in the patentability of biotechnology in Australia and the United States – Part 2. Australian Intellectual Property Law Bulletin. 30, 222–225.
[7] Kimura, S. and Burton, C.A. (2017) Pharmaceutical patent protection: the United States and Japan in comparative perspective. Pharm. Pat. Anal. 6, 35–42.
| Pharmaceutical patent protection: the United States and Japan in comparative perspective.Crossref | GoogleScholarGoogle Scholar | 28155570PubMed |
[8] Chakrabarty, A.M. (2016) Patent eligibility issues in life science innovations: contentious court cases. In Intellectual Property Issues in Biotechnology (Singh, H.B. et al., eds) pp. 17–29, CABI.
[9] Weitz, D.J. (1993) The biological deposit requirement: a means of assuring adequate disclosure. High Technol. Law J. 8, 275–306.
[10] Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure Done at Budapest on 28 April 28, 1977, and Amended on September 26, 1980; and Regulations. WIP Publication 277(E).
[11] World Intellectual Property Organization. Guide to the Deposit of Microorganisms under the Budapest Treaty. Part II, Section D. https://www.wipo.int/treaties/en/registration/budapest/guide/index.html
[12] AIPPI Standing Committee on Pharma and Biotechnology (2018) Harmonisation of Practice under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the purpose of Patent Procedure. http://aippi.org/wp-content/
